Philips, ACTREC Tata Memorial Centre Collaborate to Advance Early Cancer Detection with Spectral CT

Philips, a global health technology company, has partnered with the Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), a unit of the Tata Memorial Centre, to introduce next-generation Spectral CT imaging in India. The initiative is aimed at strengthening early cancer detection and enhancing diagnostic precision for patients with complex diseases.

With the growing burden of cancer and other multi-system conditions in India, timely and accurate diagnosis has become increasingly important. Delays in diagnosis can impact patient outcomes, while repeated imaging procedures may lead to increased radiation exposure, longer treatment timelines, and additional stress for patients, particularly in high-volume tertiary care hospitals.

The Philips Spectral CT 7500 system allows clinicians to capture detailed spectral data during standard CT scans. This capability provides deeper insights into disease characteristics through a single scan, helping doctors make faster and more confident diagnostic decisions without increasing radiation dose. The technology also supports full-body imaging in a matter of seconds, while potentially reducing the need for repeat examinations.

Clinical studies indicate that the use of Spectral CT can lead to a significant reduction in additional diagnostic procedures during complex cancer evaluations, helping minimise patient anxiety, reduce radiation exposure, and accelerate treatment planning.

According to Philips leadership, the collaboration with Tata Memorial Cancer Centre reflects a shared commitment to strengthening diagnostic capabilities in India by integrating advanced imaging technologies that improve workflow efficiency and support clinicians in delivering timely and accurate diagnoses.

At ACTREC, the adoption of Spectral CT is expected to enhance clinical practice by enabling deeper diagnostic insights from a single imaging session, allowing healthcare teams to make better-informed treatment decisions while improving operational efficiency.

The technology is expected to support multiple clinical specialties, including oncology, cardiology, neurology, and emergency medicine, where rapid and accurate diagnosis is crucial.
As part of the initiative, a joint clinical programme on Spectral CT was organised at ACTREC on February 7, 2026. During the event, the Spectral CT: Clinical Publication Compendium was unveiled, presenting insights from more than 770 global peer-reviewed publications and white papers demonstrating the clinical advantages of detector-based spectral CT technology.

Through this collaboration, Philips and ACTREC aim to further strengthen India’s diagnostic ecosystem by improving access to advanced imaging, enabling earlier disease detection, and supporting more efficient patient care pathways.